T-cell targeted therapies in autoimmune diseases.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 585, doi. 10.1002/ddr.20468
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2011 AND VI 72 AND IP 7
Results: 11
1
2
Certolizumab pegol therapy of rheumatoid arthritis: Overview.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 603, doi. 10.1002/ddr.20470
- By:
- Publication type:
- Article
3
Current management of Behçet's syndrome.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 647, doi. 10.1002/ddr.20474
- By:
- Publication type:
- Article
4
The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 573, doi. 10.1002/ddr.20467
- By:
- Publication type:
- Article
5
Clinical profile of cyclosporine in dermatology.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 634, doi. 10.1002/ddr.20473
- By:
- Publication type:
- Article
6
Current drugs in systemic lupus erythematosus.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 561, doi. 10.1002/ddr.20466
- By:
- Publication type:
- Article
7
Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 623, doi. 10.1002/ddr.20472
- By:
- Publication type:
- Article
8
Canakinumab for the treatment of adult and pediatric cryopyrin-associated periodic syndromes (CAPS).
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 553, doi. 10.1002/ddr.20465
- By:
- Publication type:
- Article
9
Emergence of small-molecule CXCR4 antagonists as novel immune and hematopoietic system regulatory agents.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 598, doi. 10.1002/ddr.20469
- By:
- Publication type:
- Article
10
Anti-tumor necrosis factor-α therapies for immune-mediated and inflammatory skin diseases.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 615, doi. 10.1002/ddr.20471
- By:
- Publication type:
- Article
11
Biomarkers: improving the cost-effectiveness of biological drugs for autoimmune disorders.
- Published in:
- Drug Development Research, 2011, v. 72, n. 7, p. 549, doi. 10.1002/ddr.20464
- By:
- Publication type:
- Article